Sarah R. Verhoeff
Heerlen, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis.
Journal: Journal of neuro-oncology
Published: August 22, 2025
[89Zr]Zr-DFO-avelumab accumulation in resectable non-small cell lung carcinoma indicates a suppressive tumor microenvironment amendable to neoadjuvant avelumab treatment.
Journal: Immunotherapy advances
Published: May 08, 2025
Safety of accelerated infusion of nivolumab and pembrolizumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 31, 2025
Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting.
Journal: Cancers
Published: January 07, 2023
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 09, 2022
89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 14, 2021
Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 30, 2021
Programmed Cell Death-1/Ligand-1 PET Imaging: A Novel Tool to Optimize Immunotherapy?
Journal: PET clinics
Published: November 19, 2019
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 29, 2019
Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
Journal: International journal of cancer
Published: September 13, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026